Coronavirus Disease 2019 (COVID-19) Re-infection by a Phylogenetically Distinct Severe Acute Respiratory Syndrome Coronavirus 2 Strain Confirmed by Whole Genome SequencingKelvin Kai‐Wang To, Kwok‐Yung Yuen, Vincent Chi‐Chung Cheng et al.|Clinical Infectious Diseases|2020Cited by 818
High neutralizing antibody titer in intensive care unit patients with COVID-19Li Liu, Zhiwei Chen, Kelvin Kai‐Wang To et al.|Emerging Microbes & Infections|2020Cited by 150
Serum Antibody Profile of a Patient With Coronavirus Disease 2019 ReinfectionKelvin Kai‐Wang To, Kwok‐Yung Yuen, Ivan Fan‐Ngai Hung et al.|Clinical Infectious Diseases|2020Cited by 64
Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variant-Associated Receptor Binding Domain (RBD) Mutations on the Susceptibility to Serum Antibodies Elicited by Coronavirus Disease 2019 (COVID-19) Infection or VaccinationLin‐Lei Chen, Kelvin Kai‐Wang To, Lu Lu et al.|Clinical Infectious Diseases|2021Cited by 51
Unique Clusters of Severe Acute Respiratory Syndrome Coronavirus 2 Causing a Large Coronavirus Disease 2019 Outbreak in Hong KongKelvin Kai‐Wang To, Kwok‐Yung Yuen, Wan-Mui Chan et al.|Clinical Infectious Diseases|2020Cited by 48